Isolation of anticancer and anti-trypanosome secondary metabolites from the endophytic fungus Aspergillus flocculus via bioactivity guided isolation and MS based metabolomics by Tawfike, Ahmed F. et al.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Isolation of anticancer and anti-trypanosome secondary metabolites from the 
endophytic fungus Aspergillus flocculus via bioactivity guided isolation and MS based 
metabolomics  
Ahmed F Tawfike
1,2,a♯*
, Muhammad Romli
1
, Carol Clements
1
, Gráinne Abbott
1
, Louise 
Young
1
, Marc Schumacher
3
, Marc Diederich
4
, Mohamed Farag
5,6
 and RuAngelie Edrada-
Ebel
1*
 
 
Affiliations 
1
Strathclyde Institute of Pharmacy and Biomedical sciences, University of Strathclyde, 
Glasgow, G4 0RE, UK 
2
Department of Pharmacognosy, Faculty of Pharmacy, Helwan University, Cairo, 11795, 
Egypt 
3
Laboratoire de Biologie Moleculaire et Cellulaire du Cancer, Fondation de Recherche 
Cancer et Sang, Hopital Kirchberg, 9 rue Edward Steichen, L-2540 Luxembourg 
4
Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, 
Gwanak-gu, Seoul, 08826, Korea 
5
Department of Chemistry, School of Sciences & Engineering, The American University in 
Cairo, New Cairo, Egypt. 
6
Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt 
 
Correspondence 
Dr RuAngelie Edrada-Ebel, Senior lecturer, Strathclyde Institute of Pharmacy and 
Biomedical sciences, University of Strathclyde, Glasgow, G4 0RE, UK 
Email: ruangelie.edrada-ebel@strath.ac.uk, Phone: +44(0)1415485968 
 
Dr Ahmed F Tawfike, Lecturer, Department of Pharmacognosy, Faculty of Pharmacy, 
Helwan University, Cairo, 11795, Egypt.  
a♯ 
Current address: Molecular discovery group, Department of Computational and Analytical 
Science, Rothamsted Research, Harpenden, AL5 2JQ, England, UK. 
Email: ahmed.tawfike@rothamsted.ac.uk, Phone: +44(0)1582938120 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Abstract 
This study aims to identify bioactive anticancer and anti-trypanosome secondary metabolites 
from the fermentation culture of Aspergillus flocculus endophyte assisted by modern 
metabolomics technologies. The endophyte was isolated from the stem of the medicinal plant 
Markhamia platycalyx and identified using phylogenetics. Principle component analysis was 
employed to screen for the optimum growth endophyte culturing conditions and revealing 
that the 30-days rice culture (RC-30d) provided the highest levels of the bioactive agents. To 
pinpoint for active chemicals in endophyte crude extracts and successive fractions, a new 
application of molecular interaction network is implemented to correlate the chemical and 
biological profiles of the anti-trypanosome active fractions to highlight the metabolites 
mediating for bioactivity prior to purification trials. Multivariate data analysis (MVDA), with 
the aid of dereplication studies, efficiently annotated the putatively active anticancer 
molecules. The small-scale RC-30d fungal culture was purified using high-throughput 
chromatographic techniques to yield compound 1, a novel polyketide molecule though 
inactive. Whereas, active fractions revealed from the bioactivity guided fractionation of 
medium scale RC-30d culture were further purified to yield 7 metabolites, 5 of which namely 
cis-4-hydroxymellein, 5-hydroxymellein, diorcinol, botryoisocoumarin A and mellein, 
inhibited the growth of chronic myelogenous leukaemia cell line K562 at 30 μM. 3-
hydroxymellein and diorcinol exhibited a respective inhibition of 56% and 97% to the 
sleeping sickness causing parasite Trypanosoma brucei brucei.  More interestingly, the anti-
trypanosomal activity of A. flocculus extract appeared to be mediated by the synergistic effect 
of the active steroidal compounds i.e. ergosterol peroxide, ergosterol and campesterol. The 
isolated structures were elucidated by using 1D, 2D NMR and HR-ESIMS. 
Keywords: 
Endophytic fungi, Aspergillus flocculus, Metabolomics, LC-MS, Anti-trypanosome, Anti-
cancer 
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1. Introduction 
Endophytes are microbes that are  harboured inside plant internal tissues without triggering  
any immediate, apparent negative effects [1].  Piling evidence points to their possible  
involvement  in the biosynthesis of plant natural products, or  even that they might be the sole 
producers of several other groups of novel pharmacologically active and structurally diverse 
secondary metabolites [2].  Advanced methods in natural products drug discovery have 
provided an access to a rich source of novel drug leads having the advantage of optimizing 
yield production levels via the large-scale cultivation of the microorganisms.  Aspergillus is a 
fungal genus belonging to Ascomycetes fungi that are found in several terrestrial and marine 
organisms.  The endophytic Aspergillus flocculus was first isolated from the stem of the 
Egyptian medicinal plant Markhamia platyclayx. Roots, stems, barks, and leaves of 
Markhamia species are used in traditional medicine to treat various ailments. In Africa, 
Markhamia plant parts were traditionally used for treating microbial and parasitic diseases, 
anaemia, diarrhoea, backache, sore eyes, pulmonary troubles, gout, scrotal elephantiasis, 
rheumatoid arthritis, and superficial skin condition [3]. In terms of chemistry, Markhamia 
species produce a myriad of metabolites i.e. antitumor naphthofurandione and 
naphthoquinones from M. tomentosa and M. hildebrandtii resepectively [4], cytotoxic sterols 
from M. zanzibarica [5], anti-parasitic triterpenoids musambins A-C and their glycosides in 
M. lutea [6] in addition to  polyphenols [7, 8].  For thorough review on  bioactive metabolites  
from the terrestrial Aspergillus endophyte, our previous publication ought to be consulted [9]. 
Continuing our interest in the metabolites profiling of plant fungal endophytes, we report 
herein on the isolation of bioactive anticancer and antitrypanosomal metabolites from A. 
flocculus guided by metabolomics modern metabolomics tools.      
In a preliminary screening for anticancer and antimicrobial active agents from endophytic 
fungi, A. flocculus an endophyte associated with the stem of M. platycalyx (Bignoniaceae) 
exhibited toxicity against prostate cancer cell line (PC3) and chronic myelogenous leukemia 
(K562) (Fig.1-3S) [9].  Cancer Research UK recorded 356,860 cancer cases in 2014 with 
estimated deaths of 163,444 which is more than 45% mortalities. Prostate cancer was the 
fourth most common cause of cancer death in the UK with more than 11.000 deaths recorded 
in 2016 [10]. According to the International Agency of Research on Cancer, an estimated 1.1 
million men worldwide were diagnosed with prostate cancer in 2012, considered as 15% of 
the cancers diagnosed in men. Between 2009 and 2013, leukaemia was the fifth most 
common cause of cancer death in men and the sixth in women. In 2017, 24,500 people in US 
are estimated to die from leukaemia (14,300 males and 10,200 females). In addition, there is 
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approximately more than 380,000 people living with, or in remission from, leukaemia [11]. 
Human African Trypanosomiasis (HAT), or sleeping sickness, is a vector-borne parasitic 
disease, caused by the parasitic protozoan T. brucei. Trypanosomiasis is one of the most 
neglected tropical diseases that occurs in sub-Saharan Africa and is regarded as being life 
threatening if left untreated. HAT affects remote rural communities in isolated regions with 
inadequate access to suitable health services, with many cases that could not be diagnosed or 
reported and ultimately affecting  the true statistics of disease prevalence in Africa [12].  All 
available medications used for HAT treatment must be taken by injection over a long-time 
thus requiring medical facilities and specialized staff that unfortunately often do not exist in 
rural infected areas. Adverse effects are severe and sometimes fatal [13].  Eradication of HAT 
is considered though possible by World Health Organization (WHO) [14]. Consequently, 
reliable methods for diagnosis, novel, safe, effective, and easy-to-apply drugs are still 
warranted [15]. Historically, natural products have been recognized as a rich source of 
compounds that have played a potential role in ailments treatment and for maintaining a 
better health status. The large structural diversity of natural products along with their myriad 
of biological effects has served as “lead” compounds for drug design programs.  In fact, Food 
and Drug Administration (FDA)  reported that 34% of discovered drugs between 1981-2010 
were derived from natural products [16]. Moreover, the recent technological advances in high 
throughput screening along with metabolomics and dereplication studies has led to a 
paradigm shift in natural products drug discovery. Metabolomics is the technology designed 
to provide general qualitative and quantitative profile of metabolites in biological systems at 
different status conditions, with many applications in aspects related to drug discoveries, 
particularly when coupled to bioactivity assay to expedite the identification of bioactive 
agents. Particularly of value among the different metabolomics platforms, liquid 
chromatography coupled to mass spectrometry LCMS can generate an informative rich data 
set that can assist in the tentative identification of natural products classes present in crude 
extracts prior to an intensive isolation attempts.  For pinpointing active components, 
multivariate data analysis is normally employed to correlate bioactivity and LCMS profiles 
[17]. In this study, we used a molecular interaction correlation network that uses the Pearson 
correlation coefficient to link the chemical and biological profile of either active extracts or 
fractions. Thus, the metabolites contributing to the bioactivity can be putatively identified 
before extensive isolation attempts.     
 
2. Materials and Methods 
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2.1. Fungal Material 
The endophytic fungus was isolated from the fresh stems of Markhamia platycalyx family 
(Bignoniaceae) collected in October 2010 from Al-Zohriya gardens (Al-Zamalek, Giza, 
Egypt). Plant material was authenticated by Dr. Therese L. Yousef, senior expert at Orman 
Garden and with the voucher specimen (No. 633) deposited. Plant material was cut into small 
pieces, washed with sterilized demineralized water, then thoroughly surface sterilized with 
70% isopropanol for 1-2 seconds and ultimately air dried under a laminar flow hood. Such 
procedure is done to eliminate surface contaminating microbes. With a sterile scalpel, outer 
tissues were removed from the plant and the inner tissues were carefully dissected under 
sterile conditions and laid over malt agar (MA) plates containing chloramphenicol to prevent 
bacterial contamination. Post 4 weeks of incubation at 30°C, hyphal tips of the fungi were 
removed and transferred to a fresh MA medium. Plates were prepared in duplicates to 
eliminate the possibility of contamination. Pure strains were isolated by repeated inoculation 
and with the purified fungus later transferred to the rice solid medium for scaling up. 
 
2.2. Identification of fungal strain 
The fungus was annotated as  as Aspergillus flocculus on the basis of sequence similarity 
of the ITS region as described previously [18]. DNA extraction and gene amplification 
was performed using (RED Extract-N-Amp™ Plant PCR Kit, Sigma-Aldrich, UK) 
following the exact protocol described by Debbab 2009 [19]. BLAST search of the 
FASTA sequence was performed with the option “nr”, including GenBank, RefSeq 
Nucleotides, EMBL, DDBJ and PDB sequences on the BLAST homepage, NCBI, 
Bethesda, USA. The GeneBank accession number was FJ491571 and fungal strain MS-F2 
was archived in the microbial culture collection of the Edrada-Ebel Research Laboratory, 
SIPBS, University of Strathclyde, UK. 
 
2.3. Extractions of endophytic metabolites for screening and metabolites profiling analysis  
A plate of each fungal species was transferred into a 250-ml flask, then macerated with 
ethyl acetate and left overnight followed by homogenization and filtration. The mycelia 
was further macerated for three more times with 200 mL ethyl acetate and filtered using 
glass Buchner filter funnel with sintered glass disc. The filtrate was then combined and 
dried under vacuum using BUCHI Rotavapor R-3 at 45°C. Dried obtained residue was 
resuspended in 200 mL distilled H2O and partitioned by adding EtOAc (3 × 200 mL) in a 
separating funnel. To remove the water-soluble content of the media, water soluble 
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portion was concentrated and then passed over HP-20 column (Approximately 400 cm
3
 of 
Diaion HP-20) using methanol as an eluent till exhaustion. Methanol and ethyl acetate 
soluble portions were concentrated via rotary evaporator and 1 mg of each extract was 
subjected to HRMS analysis, whereas 8-10 mg was aliquoted for NMR analysis.  
 
2.4. Small-Scale Fermentation, Extraction and Metabolites Isolation 
A small-scale fermentation was carried out in two Erlenmeyer flasks (1L each) on rice 
medium, which was prepared with 100 g of rice powder and approximately 100 mL of 
demineralized water just enough to cover the rice layer. The rice media was autoclaved 
prior to fungal inoculation. A 15-day fungal inoculum grown on petri dish was inoculated 
on the sterile rice medium and was allowed to grow at room temperature under static 
condition for 30 days. The fermentation was stopped by adding 500 mL of EtOAc to each 
flask. Culture media were then cut into pieces to allow complete maceration and left for 
three days. Then filtration was done followed by repeated extraction with EtOAc until 
exhaustion. The combined EtOAc extracts were evaporated under vacuum, suspended in 
200 mL H2O and partitioned by adding EtOAc (3x200 mL) in a separating funnel. The 
pooled EtOAc extracts were then taken to dryness under vacuum. A portion of EtOAc 
extract (2.6 g) was subjected to size exclusion chromatographic separation on Sephadex 
LH-20 column (25mm x 510mm) with 100% methanol as mobile phase. 11 fractions 
resulted, evaporated and subjected to TLC. Fraction 5 (code: Seph-5), has the highest 
yield (500 mg), was selected for further fractionation work on MPLC using VersaPack 
C18 silica gel column (23 x 53 mm). Flow rate was at 10 mL/min and H2O/MeOH was 
used as mobile phase at gradient elution starting at 100% H2O reaching to 100% MeOH 
for 60 minutes, which led to the isolation of 12 sub-fractions. The sub-fractions were 
evaporated and subjected to LC-HRMS and NMR analysis. Sub-fraction M6 (12 mg) 
eluted with 70% MeOH was corresponding to compound 1 (new polyketide). In order to 
optimize the best elution system, another portion of EtOAc extract (2.3 g) was subjected 
to MPLC fractionation using VersaPack silica gel column (23 x 110 mL) at a flow rate of 
15 mL/min and n-hexane/EtOAc as mobile phase with gradient elution starting at 100% 
n-hexane and reaching to 100% EtOAc in 2.1 hours run. The MPLC fractionation led to 
isolation of 253 fraction 50 mL each. Fractions were subjected to TLC where similar 
fractions were pooled and dried for further analysis. Fraction MPLC-24 (16 mg) eluted 
with 80% EtOAc was equivalent for compound 2 (dihydroaspyrone).  
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2.5. Bioactivity guided isolation of medium-scale 30-day rice culture (RC-30d) 
A medium scale fermentation was performed in 10 Erlenmeyer flasks (1L each) on rice 
solid medium for 30 days under same condition applied to small scale culture. The EtOAc 
extract of the medium scale batch of 30-day rice culture (30 g) was dried and 
reconstituted in MeOH which was slowly evaporated that led for the precipitation of 
Kojic acid crystals (3) (4.8 g) which was further purified by decantation. The rest of the 
MeOH liquor (25 g) was dried under vacuum, dissolved in 10% aqueous MeOH and 
partitioned with n-hexane in a separating funnel as a defatting step. The n-hexane soluble 
layer was concentrated and subjected to further fractionation on silica gel open column 
(19 mm x 46 mm) using DCM/EtOAc (90:10) as eluent to yield compounds 4 (ergosterol) 
8 mg, 5 (ergosterol peroxide) 7 mg and 6 (campesterol) 9 mg. While the methanol soluble 
portion (5.1 g) was fractionated on a Grace flash chromatography instrument using silica 
gel cartridge 80g (186 mm (L) x 32 mm (ID), 40μm particle size) with n-hexane and 
EtOAc as mobile phase on gradient elution started at 100% n-hexane reaching to 100% 
EtOAc in 2 hours 15 minutes. This was followed by another run, to elute the highly polar 
compounds, employing EtOAc/MeOH as a gradient elution system started at 0% MeOH 
reaching 30% MeOH in 20 minutes. The fractions were collected in 20 mL volume each, 
evaporated under nitrogen and pooled in accordance to the detector (UV and LSD) 
chromatogram and TLC. Pooled-fractions resulted from both runs, evaporated and 
subjected for further analysis. Fractions were tested for their ability to inhibit 
trypanosomal viability, potentially active fraction F18-29 was pooled with moderately 
active F11-18 to increase the yield that will be subjected to further purifications. The 
pooled fraction F11-29 (216 mg) was then further fractionated using Grace Silica 
cartridge 12g (82 mm x 22 mm) with isocratic elution system employing n-
hexane/CH2Cl2 at ratio (65:35) in 55 minutes run. This resulted in isolation of compounds 
7a and 7b in a mixture (11mg) which equivalent for botryoisocoumarin A and mellein 
respectively. Similarly, fractions F53-55, F56-64 and F65-71 were pooled into F53-71 
(157 mg) that was chromtographed on Grace silica cartridge 12g (82 mm x 22 mm) with 
isocratic elution system employing n-hexane/CH2Cl2/EtOAc at ratio (70:20:10) in 65 
minutes run which gave instantaneously 71 sub-fractions. The sub-fractions have pooled 
according to TLC and yielded 13 pooled sub-fractions. Sub-fraction F40-53 (40 mg) was 
further purified on Biotage silica cartridge SNAP 10 g (20 mm x 60 mm) using n-
hexane/CH2Cl2/EtOAc at ratio (70:20:10) in 60 minutes run to give compound 8 (cis-4-
hydroxymellein) 13 mg and 9 (trans-4-hydroxymellein) 15 mg. Fraction F72-89 (479 mg) 
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was fractionated using Grace silica cartridge 12g (82 mm x 22 mm) with isocratic elution 
system employing n-hexane/CH2Cl2/EtOAc at ratio (70:20:10) in 62 minutes run which 
gave instantly 92 sub-fractions. Sub-fractions F41-47 (60 mg) and F32-40 (53 mg) were 
applied on Biotage silica cartridge SNAP 10 g (20 mm x 60 mm) using n-
hexane/CH2Cl2/EtOAc at ratio (70:20:10) in 45 minutes run to give compounds 10 (10 
mg) and 11 (12 mg) equivalent for 3-hydroxymellein and diorcinol respectively, from 
sub-fraction F41-47. While sub fraction F32-40 yielded compound 12 corresponded to 5-
hydroxymellein. The inactive fractions were also further fractionated in search for either 
new chemistry or other bioactivities. Fraction F90-135 (2.7 g) was subjected to 
fractionation using Grace Silica cartridge 40 g (122 mm x 27 mm) with isocratic/gradient 
elution system employing CH2Cl2/MeOH commenced with 0% MeOH reaching to 3% 
MeOH in 5 min that remained for 20 min isocratic elution. Followed by gradient elution 
started at 3% MeOH to 30% in the next 20 mins. This resulted in 74 fractions, which  were 
evaporated and pooled according to TLC to give 15 sub-fractions. Sub-fraction F16-43 
(500 mg) was applied on Biotage silica cartridge SNAP 25g (29 mm x 78 mm) to be 
fractionated using n-hexane/CH2Cl2/EtOAc at ratio 70:20:10 for 30 minutes followed by 
EtOAc/MeOH gradient elution system started at 0% MeOH reaching to 30% in 20 
minutes. This resulted in elution of F113-117 (189 mg) corresponded to compound 13 (7-
O-acetyl kojic acid), F2-19 (12 mg) which corresponded to compound 14 (methyl 2-(4-
hydroxyphenyl) acetate) and F108-112 (51 mg). F108-112 was subjected to fractionation 
using preparative TLC using n-hexane/CH2Cl2/EtOAc (70:20:10) for three cycles which 
resulted in isolation of three bands at Rf values 0.8, 0.7 and 0.3 equivalent for compounds 
15 (7 mg), 16 (5mg) and 17 (11 mg) corresponded to phomaligol A, phomaligol A1 
epimer and dihydropenicillic acid respectively. Sub-fraction F51-66 (1.5 g) was 
fractionated using Grace Silica cartridge 40 g (122 mm x 27 mm) with gradient elution 
system employing CH2Cl2/EtOAc, started by 0% EtOAc reaching 100% in 55 minutes 
and followed by another run using gradient elution system EtOAc/MeOH started at 0% 
MeOH to 30% in 20 minutes. This resulted in elution of F2-8 (61 mg) which has been 
purified using preparative TLC with n-hexane/EtOAc at ratio 70:30 as a mobile phase. 
This resulted in separation of compound 18 (8 mg) equivalent for p-hydroxy 
benzaldehyde; F17-37 (520 mg) that has been subjected to fractionation using Grace 
silica cartridge 12 g (82 mm x 22 mm) with isocratic/gradient elution system employing 
CH2Cl2/MeOH. The run commenced with 0% MeOH reaching to 3% in 5 minute, 
remained at 3% MeOH for another 25 minutes and followed by gradient elution started at 
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3% MeOH reaching to 20 % in 15 minutes run. This led to isolation of F36-37 (15 mg) 
which, was a mixture of compounds 19a (2-hydroxyphenyl acetic acid) and 19b (4-
hydroxyphenyl acetic acid); F33-35 (170 mg) was purified using preparative TLC with 
mobile phase CH2Cl2/MeOH at ratio 95:5 three cycles to give a band at Rf value 0.7. The 
band was corresponded to compound 20 (17 mg) equivalent to 4, 5-dihydroxymellien. 
Scheme of the isolated compounds is shown in Fig.17S (SI).  
 
2.6. General experimental procedure 
1D and 2D-NMR experiments were recorded at 25 ᵒC in DMSO-d6 and CDCl3 on JEOL 
JNM-LA400 NMR spectrometer (JEOL, Ltd., Tokyo, Japan). Chemical shifts were 
referenced to the solvent residual peaks at δH 2.50 and 7.26 for 
1H and δC 39.5 and 77.16 for 
13
C for DMSO and CDCl3, respectively. Electrospray ionization high resolution mass 
spectrometry (ESI-HRMS) was measured using Fourier transform (FTHRMS)-Finnigan LTQ 
Orbitrap or Exactive mass spectrometer (Thermo Fisher Scientific, Massachusetts, USA). 
The samples were run in duplicate, the MS detection range was from m/z 100–2000 and 
scanning was performed under ESI polarity switching mode. The needle voltages were −4.0 
kV, 4.5 kV positive and the sheath and auxiliary gases were set at 50 and 17 arbitrary units, 
respectively. HPLC analysis was performed with Dionex UltiMate3000 (Thermo Fisher 
Scientific, Massachusetts, USA) coupled to photodiode array detector (DAD3000RS). The 
samples were chromatographed via a C-18 column (ACE) with a length of 75mm, internal 
diameter of 3.0 mm and silica particle size 5 μm. A mobile phase composed of 0.1% formic 
acid HPLC-grade water (solvent A) and acetonitrile (solvent B) set at a flow rate of 
300μL/min was used for peaks elution. Gradient elution was employed, commencing with 
10% B for 5 minutes increased to 100% B over 30 minutes, and kept for another 5 minutes 
before decreasing to 10% B. The column was then equilibrated with 10% B for 4 minutes 
until the end of run.  
A medium pressure liquid chromatography (MPLC) from BÜCHI was used for the isolation 
of fungal fractions, MPLC instrument was the Sepacore Purification System with Versaflash 
column stand (BUCHI UK Ltd, Oldham, UK). The Reveleris® Flash Forward system of 
Grace Davison Discovery Sciences (Illinois, USA) was also used for further purification, 
which is characterized of having two detectors, an evaporative light scattering detector 
(ELSD) and a UV detector (wavelength range: 200-500 nm).  
 
2.7. LC-MS data analysis, processing and visualization 
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LC-MS spectra were processed using Thermo Xcalibur 2.1 (Thermo Fisher Scientific, 
Massachusetts, USA). To convert the raw data into separate positive and negative ionisation 
files, msconvert from ProteoWizard was used [20]. The files were then imported to the data 
mining software MZmine 2.20 (VTT, Espo, Finland) for peak picking, deconvolution, 
deisotoping, alignment and formula prediction [9, 17]. Macro file of mass peaks abundance 
was written  to an Excel file, used to combine positive and negative MS files and for further 
clean-up of media components [21]. For metabolites identification via LCMS, the Dictionary 
of Natural Products (DNP) 2015 was used. MestReNova (MNova) 2.10 (MestrelabResearch, 
S.L, Santiago de Compostela, Spain) was used to process NMR data. SIMCA 14 (Umetrics 
AB, Umeå, Sweden) was used for multivariate data analysis using centre scaling. Heatmap 
was created using http://www.metaboanalyst.ca/. 
 
2.8. Molecular network 
A molecular interaction network was created via specific application of the cytoscape 
software (version 3.4.0)[22]. The ExpressionCorrelation app, implemented by Sander 
Group, (Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New 
York City), was used to compute a similarity network from either observation (active 
fractions) or their corresponding features (m/z) in data matrix. Similarity network is us ing 
the Pearson correlation coefficient to link the active fractions (observations correlation 
network) or their corresponding metabolites (features correlation network). A feature 
correlation network was created to explore which of the metabolites will be highly 
correlated with the bioactivity (represented by percentage of viability). The negative 
correlation threshold was set to 0.7 whereas the positive one was neglected. The network 
was mapped via organic yfiles layout, a kind of spring-embedded algorithm that combines 
elements to show the clustered structure of a graph. Features (metabolites) were 
represented by nodes which are linked by edges (correlation value). The width of the edge 
is corresponding to the strength of the correlation.         
 
2.9. In vitro Anti-trypanosomal activity via Alamar blue assay  
Anti-trypanosomal activity was tested following the protocol reported by (Räz et al., 
1997)[23]. Test compounds were prepared as 10 mg/mL stock solutions in 100% DMSO. 
The samples were initially screened at a concentration of 20µg/mL and then minimum 
inhibitory concentration (MIC) determinations were determined for the active 
compounds. MICs were carried out in 96-well microplates. DMSO at a concentration 
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range of 0.001–1% and suramin over a concentration range of 0.8–100 µM were included 
as negative and positive controls. 
 
2.10. Anticancer activity for crude extracts and fractions 
2.10.1. Cell culture and treatment 
Crude extracts and fractions were tested at Laboratoire de Biologie Moleculaire et 
Cellulaire du Cancer (LBMCC). The in vitro growth inhibitory ability of the extracts, 
fractions and pure compounds were tested on different cell lines including Human 
Philadelphia chromosome-positive chronic myelogenous leukemia cells (K562) and 
prostate cancer cells (PC3). The cell lines were purchased from Deutsche SammLung für 
Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany) and cultured in 
RPMI 1640 medium (Lonza, Verviers, Belgium) supplemented with 10% fetal calf serum 
(FCS) (Hyclone, Perbio, Erembodegem, Belgium) and 1% (v/v) antibiotic– antimycotic 
(Lonza, BioWhittaker™, Verviers, Belgium) at 37 ̊C, in a 5% CO2, humidified 
atmosphere. Human recombinant TNFa (PeproTech, Rocky Hill, NJ, USA) was re-
suspended in a phosphate buffer salt (PBS) 1X sterile solution containing 0.5% bovine 
serum albumin (MP Biomedicals, Asse-Relegem, Belgium) to reach a final concentration 
of 10µg/mL [24]. 
2.10.2. Transient transfection and luciferase reporter gene assay 
Transient transfections of K562 cells were achieved as previously described [25]. As 
summary, 5 μg of luciferase reporter gene construct containing five repeats of a 
consensus NF-κB site (Stratagene, Huissen, Netherlands) and 5 μg Renilla luciferase 
plasmid (Promega, Leiden, Netherlands) was utilized for each pulse. After 
electroporation, the cells were re-suspended in growth medium (RPMI/FCS 10%) and 
incubated at 37 °C which followed by 5% CO2. 20 h after transfection. The cells were 
then harvested and re-suspended in growth medium (RPMI/FCS 0.1%) to a final 
concentration of 106 cells/mL and treated for 2 h with or without the natural compound. 
Successively, the cells were challenged with 20 ng/mL TNFα for 6 h. 75 μl Dual-Glo™ 
Luciferase reagent (Promega) was added to the cells for 10 min incubation at 22 °C 
followed by measuring luciferase activity. Then, 75 μl Dual-Glo™ Stop and Glo1 reagent 
(Promega) were added for 10 min at 22 °C in order to assay Renilla activity. Luciferase 
and Renilla (Promega) activities were measured using an Orion microplate luminometer 
(Berthold, Pforzheim, Germany) by integrating light emission for 10 s. The results are 
expressed as a ratio of arbitrary units of firefly luciferase activity normalized to Renilla 
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luciferase activity [24]. 
2.10.3. In vitro cytotoxic assay (viability assay) 
The cell lines were preserved in continuous culture in a humid atmosphere at 37 °C and 
5% CO2 in RPMI 1640 medium supplemented with penicillin, streptomycin, gentamicin, 
L-glutamine, and fetal calf serum. Potential mycoplasm contaminations were checked 
twice per month. For the assay, 24-well plates were seeded with 500 µL of cell 
suspension containing 2 x 10
5
 cells/mL. Cells were treated with natural compounds at 
30μM. After 24 h incubation, the cells were transferred to 96-well microplates and 
assayed for the CellTiter-Glo® Luminescent Cell Viability Assay to calculate the number 
of viable cells in culture, based on quantification of the ATP present. Each condition was 
performed in triplicate. The results correspond to an average of three independent 
experiments ± SD [24]. 
2.11. Anticancer activity of pure compounds  
Purified compounds were tested at Strathclyde Innovations in Drug Research (SIDR) lab. 
Human Philadelphia chromosome-positive chronic myelogenous leukemia cells (K562) 
and prostate cancer cells (PC3) were purchased from the Global Bioresource Centre 
ATCC. The cells were cultured in an incubator in 5% CO2 at 37 °C and then seeded at a 
density of 2 x 10
4
 cells/well in 100 µL of the growth medium Minimum Essential 
Medium alpha (MEMα) supplemented with 20% foetal bovine serum (FBS). The growth 
medium was replaced (after 48h) with 80 µL of new medium that contained the purified 
compounds at concentrations 30 μM (mixtures are tested at 30 μg/mL). 20 µL of 50% 
PrestoBlue® (resazurin based, Life Technologies) solution (diluted with growth media) 
was added to the cells after 48h incubation for viability measurements. This mixture was 
incubated for 60 min before reading the fluorescence (570 nm excitation/585 nm 
emission). The percentage of treated cell viability was calculated and compared to 
untreated cells. Tests were done in triplicate. Additionally, cells were observed and 
micrographs taken using an EVOS XL Core imaging station (Life Technologies) with 
phase contrast before treatment, after 24 h and 48 h.  
Normal epithelial cells derived from human prostate (PNT2 cells) were obtained from 
ECACC (Sigma-Aldrich, Dorset, UK). PNT2 cells were cultured in RPMI 1640 media; 
supplemented with 10% (v/v) foetal bovine serum, 2 mM glutamine and 50 µg/mL 
penicillin/streptomycin solution (all Invitrogen, Paisley, UK) in a humidified incubator at 
37 °C in the presence of 5% CO2. The confluence of cells was 90%–95%. Consequently, 
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cells were seeded at a concentration of 3750 cells/well in clear 96 flat-bottomed plates 
and allowed to adhere overnight. After that time, purified compounds were added at a 
final concentration of 30 µM and allowed to incubate for 42 hours. Viability was 
determined using Alamar Blue® (Thermo Fisher, Paisley, UK), according to the 
manufacturer’s instructions and incubated for a further 6 h. The resulting fluorescence 
was measured using a Wallac Victor 2 1420 multi-label counter (Perkin Elmer, 
Beaconsfield, UK), in fluorescence mode: 560/590 nm (ex/em). Vehicle treated control 
cells (media with 0.3% DMSO) were considered 100% viable against which compound 
treated cells (at a concentration of 30 µM, n = 3) were compared. All results were 
confirmed microscopically [26]. 
 
3. Results and discussion 
Metabolite profiling, dereplication study and multivariate data analysis of the crude 
extracts 
We have previously developed  an high-performance liquid chromatography coupled to 
mass spectrometry (HPLC-MS) method  for profiling of fungal endophytes [17] which we 
apply herein for the profiling of A. flocculus culture. To provide a comprehensive 
coverage of A. flocculus metabolome, fungal extract was analysed in both positive and 
negative ion electrospray ionization (ESI) MS modes as changes in ESI polarity can often 
circumvent or significantly alter competitive ionization and suppression effects revealing 
otherwise suppressed metabolite signals [27]. Although different metabolite patterns 
could be observed by simple inspection of HPLC–MS chromatograms from the different 
fungal cultures (Fig.1a &b), principal component analysis (PCA) and heatmap 
multivariate data analyses were employed as a more holistic approach to determine 
relative variability within the different cultures type and help select one for the large-
scale culturing and further detailed isolation attempt. PCA is an unsupervised clustering 
method requiring no knowledge of the dataset and acts to reduce the dimensionality of 
multivariate data while preserving most of the variance within [28]. The mass signals 
extracted by MZmine 2.20 software from the raw LC–MS dataset were subjected to firstly 
PCA analysis. 
  
Fig. 1  Base peak chromatogram of A. flocculus various extracts acquired in negative (a) and positive 
ionization mode (b). Including malt agar (MA-plate), 7 days liquid culture (LC-7d), 30 days liquid 
culture (LC-30d), 7 days rice culture (RC-7d) and 30 days rice culture (RC-30d) extracts. 
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The main principal component (Fig. 2A) differentiated between the various culture 
extracts, i.e., PC1, PC2 accounted for a respective total variance 34%, 25% and revealed 
for the dispersal of the 30-day rice culture extract (RC-30d) arguing for its distinct 
chemical profile that was further confirmed from the heatmap plot (Fig. 2C). The unique 
chemical fingerprints of the RC-30d extract displayed by heatmap led to a corresponding 
discrimination in PCA score plot.  PCA loading plot (Fig.2B) highlighted the metabolites 
contributing to such segregation. Those metabolites were dereplicated using Dictionary of 
Natural Products (DNP). The resulted hits were reduced by applying a chemotaxonomic 
filter and only the predicted molecular formulas were selected from the identified hits. 
The top discriminatory compounds, corresponding to m/z (retention time in min) 475.316 
[M+H]
+ 
(35.89), 187.096 [M+H]
+ 
(3.12) and 318.279 [M+H]
+ 
(17.01), were putatively 
identified as BU-4514N (C27H42N2O5), dihydroaspyrone (C9H14O4) and preussin 
(C21H35NO), respectively. BU-4514N, antibiotic related to lydicamycin, was isolated 
from the fermentation broth of Microtetraspora sp. T689-92 and reported for its 
significant neurogenetic and antibacterial activities against gram positive bacteria [29].  
Dihydroaspyrone, a common metabolite found in Aspergillus species [30-32], reported for 
its toxicity against L-1210 (mouse lymphocytic leukaemia cells) and Methicillin-resistant 
Staphylococcus aureus (MRSA) [30]. Preussin, produced by A. ochraceus ATCC22947, 
Preussia sp. and Simplicillium lanosoniveum TAMA 173, was reported for its anti-fungal 
and cytotoxic activities [33, 34].  The bioactivities reported for the discriminatory 
metabolites of RC-30d culture indicated a promising biological and chemical metabolic 
profile. RC-30d culture extract exhibited the strongest inhibition against NF-κB (Fig.4S). 
NF-κB is a protein complex that controls transcription of DNA, cytokine production and 
overall cell survival [35]. NF-κB activation contributes to an inflammatory or immune 
response and a cellular proliferation. NF-κB inhibition consequently can suppress cancer 
growth and angiogenesis. Compounds, demonstrating NF-κB inhibition, may exhibit 
anticancer activity [36] and regulate inflammation-associated with cancer development 
[37]. Thus, the dereplication and biological investigation results encouraged the further 
purification of RC-30d fungal extract to confirm the identity of the discriminatory 
metabolites and/or exploring new chemical structures. Although, a medium scale-up 
fermentation culture of RC-30d extract was established for the bioactivity guided 
isolation of active compounds, the small-scale fermentation culture, used for optimizing 
purposes and metabolomics study, was purified to yield compounds 1 (a new polyketide) 
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and 2 (dihydroaspyrone), that were found to be inactive either against (chronic 
myologeous leukemia (K562) and prostate cancer (PC3)) cell lines or T. brucei 
(Fig.5S,6S). However, compound 1 is a new polyketide isolated herein for the first time 
from a natural source. 
 
Fig. 2 a: Principle component analysis (PCA) score plot of various culture extracts of A. flocculus b:  PCA 
loading plot of various culture extracts where metabolites are colour coded based on their m/z range, c: 
Heat map of A. flocculus culture extracts showing the metabolites pattern responsible for the variation of 
RC-30d extract 
 
Metabolite profiling, dereplication study and multivariate data analysis of the bioactive 
fractions 
The bioactivity guided fractionation of the medium-scaled RC-30-d culture led to 20 
major fractions which showed various anticancer and anti-trypanosomal activities. 
Fractions showed the strongest inhibition against T. brucei were those from 18-29 to 72-
89 with 93-100% inhibition at 20 μg/mL comparable to standard positive drug Suramin 
(Fig.7S). Moreover, F51-52 and F53-55 exhibited a significant cytotoxicity against 
chronic myelogenous leukemia cell line (K562) whereas, F53-55 was active against 
prostate cancer cell line PC3 at concentration 10 μg/mL (Fig.8S, 9S).   
To investigate which of the metabolites in the anti-trypanosome active fractions are likely 
to mediate the biological activity prior to purification attempt, a molecular interaction 
network was created by employing specific application of the cytoscape software. 
Similarity network used the Pearson correlation coefficient to link either the active 
fractions (observations correlation network) or their corresponding metabolites (features 
correlation network). Features correlation network (Fig. 3A) was implemented to assign 
metabolites significantly correlated to the bioactivity (represented by percentage of cell 
viability). The network was based only on the negative correlations. Thus, only 
metabolites having high correlation coefficient will be expected to link with the decreased 
cell viability in the bioactive fractions. Features are connected by edges (correlation 
values) where edge’s width is corresponding to the strength of this correlation. A network 
of metabolites linked to the bioactivity is depicted in Fig. 3B, with metabolites mass 
signals at m/z 952.753 [M-H]
-
, 957.766 [M+H]
+
, 251.128 [M+H]
+
, 955.757 [M+H]
+
, 
929.742 [M+H]
+
 and 778.656 [M+H]
+
, strongly connected to the bioactivity. Searching 
for their m/z against DNP database after chemotaxonomic filtration and matching the 
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predicted molecular formula, resulted in no known hits except for the molecular ion peak 
at m/z 251.128 [M+H]
+ 
eluting at 13.6 min equivalent to aspergillumarin B (C14H18O4) as 
shown in Fig. 3B. Aspergillumarin B was reported from Aspergillus sp. for its moderate 
antimicrobial activity against Staphylococcus albus [38].  
 
Fig. 3 a: Feature correlation network of the antitrypanosome active fractions, b: Extracted network of the 
metabolites strongly correlated to the bioactivity 
 
The dereplication result was further confirmed by NMR analysis of the active fractions. 
The ABC spin system on the benzene ring of aspergillumarin B was revealed from 
1
HNMR spectrum of the pooled active fractions (33-52) Fig. 4. In addition, presence of 
more than one broad peak at 11 ppm, equivalent for phenolic OH, indicates the presence 
of more than one structural analogue. To validate this work, mass spectral (MS) data for 
the isolated fractions was subjected to further multivariate data analysis (MVDA) 
(Fig.10S) to pinpoint metabolites highly correlated to the anti-trypanosomal activity in 
these fractions. Results for correlated metabolites along with their MS data are presented 
in Table 1. Hits were found comparable to those detected by molecular correlation 
network (MN) i.e. molecular ion peaks at m/z 955.757 [M+H]
+
 and 929.742 [M+H]
+
 also 
revealed by the molecular interaction network as being strongly correlated with 
bioactivity (Fig. 3B). Nevertheless, MN was superior in detecting aspergillumarin B. 
Molecular network was thus evidenced as a promising metabolomics tool for highlighting 
the active agents in either fractions or crude extracts prior to chromatographic 
purification. 
  
Fig. 4 
1
HNMR spectrum of the pooled active fractions 33-52 from RC-30d extract of A. flocculus showing 
ABC spin system of aspergillumarine analogues 
 
Table 1 Dereplication of metabolites contributing to the activity of antitrypanosome active fractions of A. 
flocculus as revealed from OPLS analysis (Fig.10S). Metabolites were arranged according to their 
statistical significance (p-values). 
 
Similarly, to pinpoint the bioactive agents in the anticancer active fraction, samples were 
classified in 2 class groups: active versus inactive. The OPLS-DA score plot (Fig.5A) 
showed a clear separation between both sample groups. The OPLS score plot explained 
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87% of the total variance (R
2
 = 0.87) with the prediction goodness parameter Q
2
 = 0.85. 
The model was validated by permutation test which revealed a permuted Q
2
 value of -
0.76 which indicated the good prediction ability of the model. Moreover, cross validation 
ANOVA (CV-ANOVA) revealed P-value 0.003 and F-test value 7.28 which confirmed 
the significance difference between the active and inactive fractions. The ANOVA F-test 
was used to assess whether any of the groups is different to the other versus the null 
hypothesis that all groups yield the same mean response. F-test statistical value was 
obtained by dividing the between-group variance by the within-group variance. A 
particularly useful tool that compares the variable magnitude against its reliability is the 
S-plot obtained by the OPLS-DA model and represented in Fig.5B, where axes plotted 
from the predictive component are the covariance p[1] against the correlation p(cor)[1]. 
S-plot displayed metabolites distinctive for the active fractions and highly correlated to 
their bioactivity. Those metabolites were dereplicated using DNP and their structure are 
presented in Fig.5. The highly-correlated metabolites at m/z (retention time in min) 
169.123 [M+H]
+
 (12.57), 239.139 [M+H]
+
 (12.59) and 295.227 [M+H]
+
 (21.94) were 
selected after the chemotaxonomic filtration and dereplicated as 5,6-dihydro-6-pentyl-2H-
pyran-2-one (from Simplicillium lamellicola) [39], N-[4-(2-formyl-5-hydroxymethyl-
pyrrol-1-yl)-butyl]-acetamide (from Fusarium incarnatum HKI00504) [40] and 
tetrahydro-6-(3-hydroxy-4,7-tridecadienyl)-2H-pyran-2-one (from Aspergillus nidulans) 
[41].  5,6-dihydro-6-pentyl-2H-pyran-2-one (known as massoia lactone) was reported for 
its significant cytotoxicity against MALME-3M human Melanoma tumor cell line [42]. 
Such results suggest for the crucial structural motifs responsible for inducing a target 
biological activity without further purification. However, to further confirm the exact 
chemical structure of these differential masses as revealed from the molecular network 
and MVDA, additional purification was attempted and to further assess its anticancer and 
antitrypanosomal activities. 
  
Fig. 5 a: OPLS-DA of anticancer fractions (●) versus the inactive (●). b: S-loading plot showing the 
putatively active molecules (coloured according to mass range) 
   
Bioactivity guided fractionation of the medium up-scaled 30-day rice solid extract (RC-
30d) led to 9 antitrypanosomal active fractions whereas two of them namely 50-52 and 
53-55 exhibited also anticancer activity (Fig.8S, 9S). The amount of the active fractions 
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was unfortunately not sufficient for further isolation attempt except for fraction (72-89). 
Hence, fractions F11-17 and F18-29 were pooled into F11-29 and similarly F53-55, 56-64 
& 65-71 were gathered into F53-71 based on their TLC pattern.  Bioactivity guided 
isolation of the three main active fractions including F11-29, F53-71 & F72-89 yielded 7 
compounds (Fig.7), of which two compounds namely 3-hydroxymellein (10) and 
diorcinol (11) demonstrated significant anti-trypanosomal activity (Fig. 6S) with a 
respective inhibition 56 % and 97%.  Diorcinol (11) was found active against T. brucei 
with an MIC of 25 μg/mL (108.7 μM). Other analogues of 3-hydroxymellein including 
botryoisocoumarin A (7a) and mellein (7b), cis-4-hydroxymellein (8), and 5-
hydroxymellein (12) isolated from the active fractions, inhibited growth of K562 cancer 
cell line at conc. 30 μM as shown in Fig.5S (compounds 7a and 7b were isolated as a 
mixture and biologically tested at conc. 30 μg/mL).  The former compounds (mellein’s 
analogues) share the same skeleton with aspergillumarin B, the compound spotted by the 
molecular network to be highly anticipated to mediate for cytotoxic activity against T. 
brucie. They are also congeners to massoia lactone, the compound detected by MVDA to 
be contributing to anticancer activity.  Such results led to the compounds are likely to be 
responsible for the biological properties of RC-30d culture extract. Additionally, 
diorcinol showed not only a cytotoxic effect against K562 cell line but also inhibited NF-
κB. 
Although, the bioactivity guided isolation, against either cancer cell lines or T. brucei, 
pointed to fraction (90-135) as inactive, isolation attempts were made considering its 
highest yield (2.7 g) and to identify other chemical structures which would be screened 
against other microorganisms i.e Mycobacterium marinum (unpublished data).  
Purification of fraction (90-135) led to the isolation of 9 compounds (Fig.7), two of which 
namely phomaligol A1 (16) and dihydropenicillic acid (17) possessed a moderate activity 
against T. brucei with MIC of 25 μg/mL (88 μM and 145.3 μM, respectively). Moreover, 
purification of hexane layer of RC-30d extract yielded three steroidal compounds; 
compound 5 (ergosterol peroxide) was found strongly active against T. brucei with MIC 
3.12 μg/mL (7.3 μM) and compound 4 (ergosterol) recorded an MIC of 12.5 μg/mL (31.6 
μM). Such results led to deduction that anti-trypanosomal activity could be due to the 
synergistic effect of diorcinol, mellein derivatives and the active steroidal compounds 
(Fig.6S). The results pointed to the importance of using more than one method of analysis 
i.e. GC-MS or NMR along with LC-MS to achieve the best metabolic coverage. 
Moreover, the study emphasized the significance of bioactivity guided isolation approach 
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as confirmative for the metabolomics results. Even though the MS based metabolomics 
did not spot the isolated active compounds, the dereplications study of the detected hits 
revealed very related structures that helped the identification of the isolated molecules.  
It should be noted that although compound 1, isolated from the small-scale extract showed 
no cytotoxic or anti-trypanosomal effect, it exhibited a novel structure first time to be 
reported in nature which we detail for its spectral assignment in the next section.  
 
Compound 1 (5,9-dihydroxy-2,4,6,8,10-pentamethyldodeca-2,6,10-trienal): isolated as 
white powder, [α]20D = –10 (c 0.05 in MeOH), HR ESIMS m/z 281.2110 [M+H]
+ 
(calcd. for 
C17H29O3). Compound 1 is partly similar to TMC-151s (Fig.11S), an antibiotic from 
Gliocladium catenulatum [43]. Apart from the extra hydrocarbon chain and sugar moiety, 
compound 1 shares the basic polyketide skeleton with TMC-151s as shown in Fig. 6, Table 2. 
The 
1
H NMR data (DMSO, 400 MHz) (Table 2, Fig.12S) showed a downfield resonance at 
δH 9.37 indicative of an aldehydic proton H-1 in addition to three protons in the olefinic 
region at δH 6.56 (d, J = 9.5 Hz), 5.33 (q, J = 6.6 Hz) and 5.25 (d, J = 5.2 Hz). Furthermore, 
two protons in the oxygenated region at δH 3.74 (d, J = 7.3 Hz) and 3.58 (d, J = 7.2 Hz); two 
protons at δH 2.77 (q, J = 7.4 Hz) and 2.46 (m). In addition, three methyl doublets at δH 0.85 
(3H, d, J = 6.6 Hz), δH 0.73 (3H, d, J = 6.8 Hz) and δH 1.53 (3H, brs) and three methyl sharp 
singlets at δH 1.65 (3H, s), δH 1.55 (3H, s) and δH 1.51 (3H, s). Moreover, the presence of two 
broad exchangeable protons at δH 4.78 and 4.26 confirmed the presence of 2 OH groups. The 
13
C NMR spectrum (400 MHz-DMSO) (Table 2, Fig.13S) showed 17 carbon signals 
including six methyl groups at δC 11.8 (C-12), 9.7 (C-13), 17.4 (C-14), 12.2 (C-15), 18.6 (C-
16) and 13.4 (C-17). Three olefinic quaternary carbons were detected at δC 138.4 (C-2), 136.2 
(C-6) and 138.1 (C-10), furthermore three olefinic methines at δC 160.0 (C-3), 131.4 (C-7) 
and 120.0 (C-11). In addition, two methines at δC 37.9 (C-4) and 36.5 (C-8), two oxygenated 
methine carbons were assigned at δC 81.0 (C-5) and 81.5 (C-9) and the carbonyl of the 
aldehyde group at δC 196.0 (C-1). The 
1
H-
1
H COSY spectrum (Fig.14S) showed three spin 
systems, the first connected δH 6.56 with 2.77 and methyl doublet at δH 0.85 assigned for H-3, 
H-4 and Me-14 respectively and further confirmed by correlation of H-4 with the oxygenated 
proton at δH 3.74 and the exchangeable proton δH 4.78 which can be assigned as H-5 and OH-
5 respectively; along with the allylic coupling between H-3 and the sharp methyl singlet δH 
1.65 for Me-13 (Bold red, Fig.6A). The second spin system connected δH 5.25 with 2.46 and 
methyl doublet at δH 0.73 assigned as H-7, H-8 and Me-16 respectively (Bold black, Fig.6A). 
Similarly, H-8 was further linked with the oxygenated δH 3.58 (H-9) and exchangeable OH-9 
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at δH 4.26; H-7 correlated with methyl singlet at δH 1.55 (Me-15). The third spin system 
correlated the third methyl doublet at δH 1.53 equivalent to Me-12 with the olefinic proton at 
δH 5.33 assigned for H-11. The structure was further confirmed from the HMBC spectrum 
(Fig.15S) via the key cross peak correlations of the allylic protons of H-3 at δH 6.57 with 
carbons (δC) C-13 (9.7), C-14 (17.4), C-4 (37.9), C5 (81.0) and C1 (196.0). Furthermore, H-7 
at δH 5.25 with carbons (δC) C-15 (12.2), C-16 (18.6), C-8 (36.5) and C-5 (81.0); H-11 (δH 
5.33) with carbons at δC 13.4 and 81.5 equivalent for C-17 and C-9 respectively. Moreover, 
the position of OH-5 and OH-9 was confirmed from the correlations of H-5 (δH 3.74) with C-
15, C-14, C-4, C-7 (δC 131.4) and C-3 (δC 160.0); H-9 (δH 3.58) with C-12 (δC 11.8), C-16, 
C-8, C-11 (δC 120.0), C-7 and C-10 (δC 138.1) (Table.2). The relative configuration between 
the hydroxyl group at C-9 and the methyl group (Me-16) at C-8 was established by 1H–1H 
coupling constant and ROESY correlations at these stereocenters (Fig.16S). The large 
coupling constant (7.1 Hz) between H-8 and H-9 defined their anti orientation. Since H-8 and 
H-9 were fixed as anti, the ROESY couplings shown in (Fig.15S) demonstrated a syn 
relationship of Me-16 and H-9 which consequently defined an anti relationship between the 
methyl group (Me-16) and the hydroxyl group at C-9 (Fig.6B). By a similar logic, the OH 
group at C-5 has anti orientation with the aliphatic methyl group (Me-14). Searching the 
databases for compound 1 confirmed it was not described before. The closest structure in the 
literature described by Kohno et al., 1999 [43] (Fig.16S) was a polyketide molecule (TMC-
151s) with an extra substitution at C-1 forming an ester linkage which was found up-field at 
δC 167.2 when compared to the aldehydic C-1 (δC 196.0) of compound 1. Consequently, 
compound 1 (Fig. 6) is designated as a new compound first time to be reported in nature. The 
structure was further confirmed by comparison of compound 1 to the closely related structure 
of polyketide TMC-151s (Table 2). 
 
Fig. 6 Structure of novel compound 1 isolated from A. flocculus showing a: HMBC correlations (arrows) 
and H-H spin systems (coloured bold bonds) and b: ROESY correlation assigning stereochemistry of OH 
groups 
 
Table 2 
1
H NMR, 
13
C NMR data and HMBC correlations of compound 1 in comparison to that 
reported for the reported analogue ‘’TMC-151s’’ 
 
Identification of the known compounds  
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Nineteen known compounds (Fig.7) were identified by the spectroscopic data analysis 
(Supporting information) and comparison with literature values. They were identified as 
dihydroaspyrone (2) [44], kojic acid (3) [45], ergosterol (4) [46], ergosterol peroxide (5) 
[47], campesterol (6) [48], botryoisocoumarin A (7a) [49], mellein (7b) [50], cis-4-
hydroxymellein (8) [51], trans-4-hydroxymellein (9) [51], 3-hydroxymellein (10) [49], 
diorcinol (11) [52], 5-hydroxymellein (12) [53], 7-O-acetyl kojic acid (13) [54], methyl 2-
(4-hydroxyphenyl) acetate (14), phomaligol A (15) [55], phomaligol A1 (16) [55], 
dihydropenicillic acid (17) [56], p-hydroxybenzaldehyde (18) [57], 2-hydroxyphenyl 
acetic acid (19a) [58], 4-hydroxyphenyl acetic acid (19b) [59] and 4,5-dihydroxymellein 
(20) [60].  
 
Fig. 7 Structures of the isolated known compounds (2-20) 
 
4. Conclusion 
In conclusion, results provided a realistic, compound-based rational for the anticancer and 
anti-trypanosomal principles present in Aspergillus flocculus.  Additionally, they pointed to 
an additional evidence for the efficacy and complementarity of LC-MS metabolites profiling 
when coupled to bioassays in the field of natural product based drug discovery, to speed up 
the traditional lengthy processes of identifying an active principle by consecutive isolation 
from crude extracts. The emerging spectroscopic and informatics technologies can indeed 
help to narrow the gap that has opened to modern synthesis based drug discovery and with 
the pressure towards a shorter time in the discovery of bioactive agents from natural 
resources. Multivariate data analysis viz. PCA revealed the most unique fungal extract in 
terms of chemical composition. Moreover, the study presented an efficient use of the 
similarity molecular interaction network along with OPLS-DA to highlight the metabolites 
strongly correlated to the featured bioactivity prior to purification attempts. Dereplication 
studies, based on the chemotaxnomic sorting proposed the putative active agents whereas 
structural assignment of isolated compounds, employed both HR-MS and NMR, confirmed 
the identified hits.  Although, it should be noted that two of the most active antitrypansomal 
agents (ergosterol and ergosterol peroxide) were not revealed from HPLC-MS analysis which 
suggest that in case of anti-trypanosomal effect, activity might be due to synergism of more 
than one component i.e mellein derivatives, diorcinol and compounds undetected using LC-
MS. We forecast that the implementation of other universal metabolites profiling 
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technologies namely 1D- and 2D-NMR applied on fungal crude extracts and fractions could 
provide better coverage of investigated metabolome and result in a gradual shift from the 
common isolation procedure. The application of metabolomics in drug discovery from 
endophytes has also yet to be fully examined compared to that reported in planta. 
 
 
Supporting information 
1D, 2D NMR spectra of compound 1, 
1
H, 
13
CNMR data of the known compounds and 
bioactivity charts are available as supporting information.  
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Table 3: Dereplication of metabolites contributing to the activity of antitrypanosome active fractions of A. 
flocculus as revealed from OPLS analysis (Fig.10S). Metabolites were arranged according to their 
statistical significance p-values. 
m/z
 
Retention 
time 
Molecular 
weight 
Name/formula Biological source Probability 
955.757 
[M+H]
+
 
31.89 954.749 Unknown 
C55H98O7N6 
 1.12E-06 
929.742 
[M+H]
+
 
31.64 928.735 Unknown 
C53H96O7N6 
 2.25E-05 
904.761 
[M+H]
+
 
31.92 903.754 Unknown 
C57H95N9 
 0.000474 
909.717 
[M+H]
+
 
31.54 908.71 Unknown 
C55H94O7N3 
 0.001501 
935.732 
[M+H]
+
 
29.79 934.725 Unknown 
C57H96O7N3 
 0.002307 
293.212 
[M-H]
- 
20.86 294.219 Tetrahydro-6-(3-hydroxy-
4,7-tridecadienyl)-2H-pyran-
2-one 
C18H30O3 
Aspergillus nidulans 0.002518 
267.159 
[M+H]
+
 
17.06 266.152 Aspterric acid / Avenaciolide 
/ Daldinin C-1''-Deoxy, 2''-
hydroxyl 
C15H22O4 
Aspergillus terreus, A. 
avenaceus, A. ustus 
094102 
0.022793 
309.207 
[M-H]
-
 
19.31 310.214 Cephalosporolide H / Lach-
nelluloic acid 
C18H30O4 
Penicillium sp., Lach-
nellula fuscosanguinea 
0.025089 
169.123 
[M+H]
+
 
15.57 168.115 5,6-Dihydro-6-pentyl-2H-
pyran-2-one 
C10H16O2 
Simplicillium lamellico-
la BCP 
0.042953 
283.154 
[M+H]
+
 
15.92 282.147 1,7-Dihydroxy-1,3,5-
bisabolatrien-15-oic acid, 11-
hydroxy 
C15H22O5 
Aspergillus sydowii 0.046196 
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Table 4: 
1
H NMR, 
13
C NMR data and HMBC correlations of compound 1 in comparison to that 
reported for its closest analogue ‘’TMC-151s’’ 
Atom 
No. 
Compound 1-d-DMSO TMC-151s-d-DMSO 
(Kohno 1999) 
 δH (m, J in Hz) δC (m) HMBC correlations δH (m, J in Hz) δC (m) 
1 9.37 (s) 196.0 (CH) C-13, C-2, C-3  167.2 (C) 
2  138.4 (C)   126.5 (C) 
3 6.57 (d, 7.7 Hz) 160.0 (CH) C-13, C-14, C-4, C-5, C-1 6.70 (d, 10.1 Hz) 146.8 (CH) 
4 2.77 (q, 7.7 Hz) 37.9 (CH) C-14, C-5, C-3, C-2 2.56 (m) 36.9 (CH) 
5 3.74 (d, 7.7 Hz) 81.0 (CH) C-15, C-14, C-4, C-7, C-3 3.67 (m) 80.9 (CH) 
6  136.1 (C)   136.0 (C) 
7 5.25 (d, 9.0 Hz) 131.4 (CH) C-15, C-16, C-8, C-5 5.19 (br. d, 9.0 Hz) 131.6 (CH) 
8 2.46 (m) 36.5 (CH) C-16, C-9, C-7, C-6 2.45 (m) 36.1 (CH) 
9 3.58 (d, 7.1 Hz) 81.5 (CH) C-12, C-16, C-8, C-11, C-
7, C-10 
3.55 (dd, 8.5, 3.4 
Hz) 
81.2 (CH) 
10  138.1 (C)   134.5 (C) 
11 5.33 (q, 6.6 Hz) 120.0 (CH) C-17, C-9 5.39 (br.d, 9.0 Hz) 130.1 (CH) 
12 1.53 (br. s) 11.8 (CH3)    
13 1.65 (s) 9.7 (CH3) C-2, C-3, C-1 1.80 (d, 1.0 Hz) 12.6 (CH3) 
14 0.85 (d, 7.7 Hz) 17.4 (CH3) C-4, C-5, C-3 0.76 (d, 6.8 Hz) 16.4 (CH3) 
15 1.55 (s) 12.2 (CH3) C-5, C-7 1.56 (br. s) 11.0 (CH3) 
16 0.73 (d, 6.8 Hz) 18.6 (CH3) C-8, C-9, C-7 0.70 (d, 6.8 Hz) 17.4 (CH3) 
17 1.51 (s) 13.4 (CH3) C-10, C-11, C-9 1.55 (br. s) 11.3 (CH3) 
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Highlights 
1. A combination of bioactivity guided-isolation and MS based-metabolomics was 
adopted for the target analysis of bioactive secondary metabolites  
2. Multivariate data analysis and molecular correlation networks were implemented for 
samples classification and detection of bioactive agents 
3. A new polyketide molecule was isolated  
4. Antitrypanosomal and anticancer activities of the purified compounds were assessed      
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